These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 37850586
1. Analysis of "Hybrid Closed Loop Using a Do-It-Yourself Artificial Pancreas System in Adults With Type 1 Diabetes". Wilkinson TM, de Bock M. J Diabetes Sci Technol; 2024 Jul; 18(4):897-898. PubMed ID: 37850586 [Abstract] [Full Text] [Related]
2. Hybrid Closed Loop Using a Do-It-Yourself Artificial Pancreas System in Adults With Type 1 Diabetes. Nanayakkara N, Sharifi A, Burren D, Elghattis Y, Jayarathna DK, Cohen N. J Diabetes Sci Technol; 2024 Jul; 18(4):889-896. PubMed ID: 36788715 [Abstract] [Full Text] [Related]
3. Do-It-Yourself Artificial Pancreas Systems: A Review of the Emerging Evidence and Insights for Healthcare Professionals. Jennings P, Hussain S. J Diabetes Sci Technol; 2020 Sep; 14(5):868-877. PubMed ID: 31847570 [Abstract] [Full Text] [Related]
6. Study protocol for a randomised open-label clinical trial examining the safety and efficacy of the Android Artificial Pancreas System (AAPS) with advanced bolus-free features in adults with type 1 diabetes: the 'CLOSE IT' (Closed Loop Open SourcE In Type 1 diabetes) trial. Wilkinson T, Tomic D, Boyle E, Burren D, Elghattis Y, Jenkins A, Keesing C, Middleton S, Nanayakkara N, Williman J, de Bock M, Cohen ND. BMJ Open; 2024 Feb 20; 14(2):e078171. PubMed ID: 38382954 [Abstract] [Full Text] [Related]
12. Pre-school and school-aged children benefit from the switch from a sensor-augmented pump to an AndroidAPS hybrid closed loop: A retrospective analysis. Petruzelkova L, Jiranova P, Soupal J, Kozak M, Plachy L, Neuman V, Pruhova S, Obermannova B, Kolouskova S, Sumnik Z. Pediatr Diabetes; 2021 Jun 20; 22(4):594-604. PubMed ID: 33576551 [Abstract] [Full Text] [Related]
13. New closed-loop insulin systems. Boughton CK, Hovorka R. Diabetologia; 2021 May 20; 64(5):1007-1015. PubMed ID: 33550442 [Abstract] [Full Text] [Related]
17. DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home. Biester T, Nir J, Remus K, Farfel A, Muller I, Biester S, Atlas E, Dovc K, Bratina N, Kordonouri O, Battelino T, Philip M, Danne T, Nimri R. Diabetes Obes Metab; 2019 Apr 20; 21(4):822-828. PubMed ID: 30478937 [Abstract] [Full Text] [Related]
18. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial. Haidar A, Legault L, Dallaire M, Alkhateeb A, Coriati A, Messier V, Cheng P, Millette M, Boulet B, Rabasa-Lhoret R. CMAJ; 2013 Mar 05; 185(4):297-305. PubMed ID: 23359039 [Abstract] [Full Text] [Related]
19. Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study. Thabit H, Lubina-Solomon A, Stadler M, Leelarathna L, Walkinshaw E, Pernet A, Allen JM, Iqbal A, Choudhary P, Kumareswaran K, Nodale M, Nisbet C, Wilinska ME, Barnard KD, Dunger DB, Heller SR, Amiel SA, Evans ML, Hovorka R. Lancet Diabetes Endocrinol; 2014 Sep 05; 2(9):701-9. PubMed ID: 24943065 [Abstract] [Full Text] [Related]